Trial Profile
Flortaucipir (18F) PET Imaging in the BIOCARD Study
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 09 Sep 2021
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Cognition disorders
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 30 Jul 2021 Results presented at the Alzheimer's Association International Conference 2021
- 07 Dec 2018 Status changed from recruiting to discontinued study terminated due to lower than expected enrollment
- 01 Mar 2018 Planned End Date changed from 31 Jan 2018 to 31 Jan 2019.